205 related articles for article (PubMed ID: 20367223)
1. Osteoarthritis: another component of metabolic syndrome?
Velasquez MT; Katz JD
Metab Syndr Relat Disord; 2010 Aug; 8(4):295-305. PubMed ID: 20367223
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data.
Puenpatom RA; Victor TW
Postgrad Med; 2009 Nov; 121(6):9-20. PubMed ID: 19940413
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
4. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care.
Lender D; Sysko SK
Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
Zarich SW
Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
[TBL] [Abstract][Full Text] [Related]
6. New insights into understanding cardiometabolic risk. Introduction.
Fonarow GC; Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
[No Abstract] [Full Text] [Related]
7. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
8. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
Abete I; Goyenechea E; Zulet MA; Martínez JA
Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
10. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome.
Reaven P
J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
13. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan.
Yasein N; Ahmad M; Matrook F; Nasir L; Froelicher ES
East Mediterr Health J; 2010 Apr; 16(4):375-80. PubMed ID: 20795419
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of the metabolic syndrome, 2002.
Meigs JB
Am J Manag Care; 2002 Sep; 8(11 Suppl):S283-92; quiz S293-6. PubMed ID: 12240700
[TBL] [Abstract][Full Text] [Related]
17. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
Kendall DM; Harmel AP
Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome & obesity: co-epidemics could overwhelm home health care.
Pearce LC
Caring; 2003 Jun; 22(6):24-8, 30, 32-3; quiz 34-6. PubMed ID: 12905569
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: is it a syndrome? Does it matter?
Kahn R
Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
[No Abstract] [Full Text] [Related]
[Next] [New Search]